Moderna said on Wednesday it had applied with the US Food and Drug Administration (FDA) for authorization of its COVID-19 booster vaccine for all adults aged 18 and older, Reuters reports.
The FDA last month cleared booster shots of Moderna’s COVID-19 vaccines for people who are immunocompromised, those aged 65 and older and for individuals at high risk of severe disease or who are regularly exposed to the virus.